Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Normal disposition of oxazepam in acute viral hepatitis and cirrhosis.

    Shull HJ, Wilkinson GR, Johnson R, Schenker S.

    Ann Intern Med. 1976 Apr;84(4):420-5.PMID: 769632 [PubMed - indexed for MEDLINE]Related articles

    2.

    The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

    Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR.

    J Clin Invest. 1975 Feb;55(2):347-59.PMID: 1127104 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The effect of liver disease in man on the disposition of phenobarbital.

    Alvin J, McHorse T, Hoyumpa A, Bush MT, Schenker S.

    J Pharmacol Exp Ther. 1975 Jan;192(1):224-35.PMID: 235636 [PubMed - indexed for MEDLINE]Related articles

    4.

    The influence of liver dysfunction on the pharmacokinetics of carprofen.

    Holazo AA, Chen SS, McMahon FG, Ryan JR, Konikoff JJ, Brazzell RK.

    J Clin Pharmacol. 1985 Mar;25(2):109-14.PMID: 3886707 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical pharmacokinetics of oxazepam and lorazepam.

    Greenblatt DJ.

    Clin Pharmacokinet. 1981 Mar-Apr;6(2):89-105. Review.PMID: 6111408 [PubMed - indexed for MEDLINE]Related articles

    6.

    Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.

    Patel M, Tang BK, Grant DM, Kalow W.

    Pharmacogenetics. 1995 Oct;5(5):287-97.PMID: 8563769 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of liver disease on the disposition of ciramadol in humans.

    Hoyumpa AM, Brown MW, Johnson R, Troxell R, Snowdy P, Schenker S.

    J Clin Pharmacol. 1989 Mar;29(3):217-24.PMID: 2723108 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of age and chronic liver disease on the elimination of temazepam.

    Ghabrial H, Desmond PV, Watson KJ, Gijsbers AJ, Harman PJ, Breen KJ, Mashford ML.

    Eur J Clin Pharmacol. 1986;30(1):93-7.PMID: 2872062 [PubMed - indexed for MEDLINE]Related articles

    9.

    Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.

    Abernethy DR, Greenblatt DJ, Ochs HR, Weyers D, Divoll M, Harmatz JS, Shader RI.

    Clin Pharmacol Ther. 1983 May;33(5):628-32.PMID: 6132698 [PubMed - indexed for MEDLINE]Related articles

    10.

    Disposition of oxazepam in patients on maintenance hemodialysis.

    Ochs HR, Greenblatt DJ, Klehr U.

    Klin Wochenschr. 1984 Aug 16;62(16):765-7.PMID: 6482312 [PubMed - indexed for MEDLINE]Related articles

    11.

    Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.

    Breyer-Pfaff U, Seyfert H, Weber M, Egberts EH.

    Eur J Clin Pharmacol. 1984;26(1):95-101.PMID: 6143671 [PubMed - indexed for MEDLINE]Related articles

    12.

    Chlordiazepoxide and oxazepam disposition in cirrhosis.

    Sellers EM, Greenblatt DJ, Giles HG, Naranjo CA, Kaplan H, MacLeod SM.

    Clin Pharmacol Ther. 1979 Aug;26(2):240-6.PMID: 455893 [PubMed - indexed for MEDLINE]Related articles

    13.

    Renal disease, age, and oxazepam kinetics.

    Murray TG, Chiang ST, Koepke HH, Walker BR.

    Clin Pharmacol Ther. 1981 Dec;30(6):805-9.PMID: 7307429 [PubMed - indexed for MEDLINE]Related articles

    14.

    Oxidative versus conjugative biotransformation of temazepam.

    Locniskar A, Greenblatt DJ.

    Biopharm Drug Dispos. 1990 Aug-Sep;11(6):499-506.PMID: 2207300 [PubMed - indexed for MEDLINE]Related articles

    15.

    Bioavailability and elimination of nitrendipine in liver disease.

    Dylewicz P, Kirch W, Santos SR, Hutt HJ, Mönig H, Ohnhaus EE.

    Eur J Clin Pharmacol. 1987;32(6):563-8.PMID: 3653225 [PubMed - indexed for MEDLINE]Related articles

    16.

    Dipyrone metabolism in liver disease.

    Zylber-Katz E, Caraco Y, Granit L, Levy M.

    Clin Pharmacol Ther. 1995 Aug;58(2):198-209.PMID: 7648770 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Metabolism of hexobarbital in patients with acute hepatitis and cirrhosis (author's transl)]

    Richter E, Gallenkamp H, Keller B, Brachtel D, Zilly W, Breimer DD.

    Z Gastroenterol. 1977 Jun;15(6):381-8. German. PMID: 888488 [PubMed - indexed for MEDLINE]Related articles

    18.

    Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate.

    Dreyfuss D, Shader RI, Harmatz JS, Greenblatt DJ.

    J Clin Psychiatry. 1986 Oct;47(10):511-4.PMID: 3759915 [PubMed - indexed for MEDLINE]Related articles

    19.

    Altered elimination of antipyrine in patients with acute viral hepatitis.

    Burnett DA, Barak AJ, Tuma DJ, Sorrell MF.

    Gut. 1976 May;17(5):341-4.PMID: 1278717 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Half-life time or clearance of indocyanine green in patients with liver disease.

    Gilmore IT, Marigold JH, Thompson RP.

    Hepatogastroenterology. 1982 Apr;29(2):55-7.PMID: 7084884 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data